CJC-1295 No DAC
Public supplier report and marketplace listing from Vital Edge Science.
Supplier testing information
Product Overview
CJC-1295 No DAC (Modified GRF 1-29) is supplied by Vital Edge Science for growth hormone signalling, recovery pathway, IGF-1, and endocrine research applications. This batch features independent Janoshik verification, Australia and New Zealand fulfilment support, and high-purity lyophilised peptide material for laboratory research use.
Available Formats
- 10mg × 1 vial
- 10mg × 10 vials
- MOQ: 1 vial
- Australia / New Zealand fulfilment
Batch Verification
- Purity: 99.855%
- Tested: 10 NOV 2025
- Task Number: #87211
- Verification Key: CT5UC7T9YWE4
Research Applications
- Growth hormone signalling research
- IGF-1 pathway investigations
- Recovery and regeneration models
- Endocrine system studies
- Body composition research
CJC-1295 No DAC laboratory testing questions
What is this CJC-1295 No DAC report?
This report contains publicly accessible batch testing information for CJC-1295 No DAC, including task number #87211, reported purity results, and Janoshik-linked laboratory reference data.
Has this CJC-1295 No DAC batch been laboratory tested?
Yes. This CJC-1295 No DAC batch includes publicly accessible laboratory testing references, including reported purity result 99.855%, task number #87211, and laboratory reference key CT5UC7T9YWE4.
Who supplied this CJC-1295 No DAC batch?
Vital Edge Science supplied this CJC-1295 No DAC batch from Australia & New Zealand, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this CJC-1295 No DAC batch?
The reported purity result for this CJC-1295 No DAC batch was 99.855%.
Where can I view additional CJC-1295 No DAC reports?
Additional CJC-1295 No DAC laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.